Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human C4a Protein, N-His

Catalog #:   YHC45302 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P0C0L4
Protein length: Asn680-Arg756
Overview

Catalog No.

YHC45302

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Asn680-Arg756

Predicted molecular weight

11.07 kDa

Nature

Recombinant

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P0C0L4

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

C4a anaphylatoxin, CO4, CPAMD2, Acidic complement C4, C4A, Complement C4-A, C3 and PZP-like alpha-2-macroglobulin domain-containing protein 2

Note

For research use only.

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human C4a protein
References

Low C4A copy numbers and higher HERV gene insertion contributes to increased risk of SLE, with absence of association with disease phenotype and disease activity., PMID:38594415

Proteomics in Patients with Fibromyalgia Syndrome: A Systematic Review of Observational Studies., PMID:38652420

Electrophoresis-Based Approach for Characterizing Dendrimer-Protein Interactions: A Proof-of-Concept Study., PMID:38753577

Comparison of CTX-M encoding plasmids present during the early phase of the ESBL pandemic in western Sweden., PMID:38789462

Genetic associations in ankylosing spondylitis: circulating proteins as drug targets and biomarkers., PMID:38835753

Serum proteomic analysis uncovers novel serum biomarkers for depression., PMID:38895030

Identification of novel therapeutic targets for chronic kidney disease and kidney function by integrating multi-omics proteome with transcriptome., PMID:38898508

Complement system molecules: Expression and regulation at the maternal-conceptus interface during pregnancy in pigs., PMID:39004297

A multi-ethnic proteomic profiling analysis in Alzheimer's disease identifies the disparities in dysregulation of proteins and pathogenesis., PMID:39035156

Analysis of the complement component C4 gene with schizophrenia subphenotypes., PMID:39084106

Decoding the genetic landscape of juvenile dermatomyositis: insights from phosphorylation-associated single nucleotide polymorphisms., PMID:39085621

Sequential window acquisition of all theoretical mass spectra (SWATH-MS) as an emerging proteomics approach for the discovery of dark-cutting beef biomarkers., PMID:39096797

Kidney whole-transcriptome profiling in primary antiphospholipid syndrome reveals complement, interferons and NETs-related gene expression., PMID:39107892

Causal relationship between complement C1QB and colorectal cancer: a drug target Mendelian randomization study., PMID:39109334

Different Complement Activation Patterns Following C5 Cleavage in MOGAD and AQP4-IgG+NMOSD., PMID:39133885

Proteomic analysis of laser captured tubular tissues reveals complement activation and mitochondrial dysfunction in autoimmune related kidney diseases., PMID:39164435

Unveiling potential drug targets for lung squamous cell carcinoma through the integration of druggable genome and genome-wide association data., PMID:39175755

Different Proteomic Profiles Regarding Antihypertensive Therapy in Preeclampsia Pregnant., PMID:39201423

Lipidomic and Proteomic Insights from Extracellular Vesicles in Postmortem Dorsolateral Prefrontal Cortex Reveal Substance Use Disorder-Induced Brain Changes., PMID:39211229

The structure of Chlamydomonas LOV1 as revealed by time-resolved serial synchrotron crystallography., PMID:39212519

Impact of Preanalytical Procedures on Complement Biomarkers in Cerebrospinal Fluid and Plasma from Controls and Alzheimer's Disease Patients., PMID:39213066

Effect of Kruppel-like factor 4 on PTZ-induced acute seizure mice., PMID:39234952

Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes., PMID:39251599

Proteomic analysis of cerebrospinal fluid of amyotrophic lateral sclerosis patients in the presence of autologous bone marrow derived mesenchymal stem cells., PMID:39278909

Sex-dependent association study of complement C4 gene with treatment-resistant schizophrenia and hospitalization frequency., PMID:39342786

CSF complement proteins are elevated in prodromal to moderate Alzheimer's disease patients and are not altered by the anti-tau antibody semorinemab., PMID:39369294

Mechanistic Perspective on Oxygen Activation Chemistry by Flavoenzymes., PMID:39424594

High-abundance serum glycoproteins as valuable resources for glycopeptide standards., PMID:39486975

Regioselective Synthesis of Potential Non-Quinonoid Prodrugs of Plasmodione: Antiparasitic Properties Against Two Hemoglobin-Feeding Parasites and Drug Metabolism Studies., PMID:39598657

Africanized honeybee venom (Apis mellifera) promotes human complement activation split products storm., PMID:39606222

Complement Activation Profiles Predict Clinical Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease., PMID:39661937

Proteomic signatures of Alzheimer's disease and Lewy body dementias: A comparative analysis., PMID:39711511

Comparative proteomic analysis reveals the response mechanism of freshwater leech (Whitmania pigra) under heat-stress challenge., PMID:39729945

Aberrant Complement Activation Is Associated With Structural Brain Damage in Multiple Sclerosis., PMID:39752618

Avian pathogenic Escherichia coli alters complement gene expression in chicken erythrocytes., PMID:39757946

Unlocking the catalytic precision of ligand-controlled enzymatic halogenation., PMID:39793036

Association of C4 Null Alleles and Persistently Low C4 in Asian Indian Patients With Systemic Lupus Erythematosus., PMID:39800843

N-terminomics profiling of host proteins targeted by excretory-secretory proteases of the nematode Angiostrongylus vasorum identifies points of interaction with canine coagulation and complement cascade., PMID:39813225

Mechanisms and applications of bacterial luciferase and its auxiliary enzymes., PMID:39824239

Use of brain MRI and gene expression atlases to reconstruct the pathophysiology of autoimmune neurological disorders: The proof-of-concept of NMOSD., PMID:39891565

Plasma proteome fingerprint in kidney diseases., PMID:39896931

Integrative Multi-omics Analysis and Mendelian Randomization Reveal Potential Therapeutic Targets and their Stratification in Lung Squamous Cell Carcinoma., PMID:39936431

HTRA1 and complement activation in neovascular age-related macular degeneration., PMID:39937341

Genome-wide mapping of complement system proteins for islet autoimmunity in the DAISY and TEDDY children., PMID:39989961

Assessment of complement cascade components in patients with major depressive disorder., PMID:40064429

Genetically druggable targets for MAPK-activated colorectal cancer by a two-sample mendelian randomization analysis., PMID:40210889

Proteomic and In Silico Analyses Highlight Complement System's Role in Bladder Cancer Immune Regulation., PMID:40283026

Proteomic Insights into IgA Nephropathy: A Comprehensive Analysis of Differentially Expressed Proteins in the Kidney., PMID:40352523

Complement component C4a binds to oxytocin and modulates plasma oxytocin concentrations and social behavior in male mice., PMID:40393160

Comprehensive Mendelian randomization analysis and experimental investigation identifies the causal relationship between immunity and kidney stone disease., PMID:40498118

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human C4a Protein, N-His [YHC45302]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only